Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial
- 1 April 2002
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 359 (9315), 1365-1372
- https://doi.org/10.1016/s0140-6736(02)08348-4
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Acute asymptomatic hepatitis in a healthy normal volunteer exposed to 2 oral doses of amodiaquine and artesunateTransactions of the Royal Society of Tropical Medicine and Hygiene, 2001
- Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trialThe Lancet, 2001
- Adverse drug reactions: definitions, diagnosis, and managementThe Lancet, 2000
- Severe falciparum malariaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2000
- Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trialThe Lancet, 2000
- Systematic review of amodiaquine treatment in uncomplicated malariaThe Lancet, 1996
- Strategies for the prevention of antimalarial drug resistance: Rationale for combination chemotherapy for malariaParasitology Today, 1996
- Atovaquone and proguanil for Plasmodium falciparum malariaThe Lancet, 1996
- Adverse Effects of AntimalarialsDrug Safety, 1993
- Severe and complicated malariaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1990